Lumexa Imaging Holdings, Inc. (LMRI)
| Market Cap | 1.35B |
| Revenue (ttm) | 1.06B +5.3% |
| Net Income | -17.05M |
| EPS | -0.19 |
| Shares Out | 96.12M |
| PE Ratio | n/a |
| Forward PE | 16.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 339,802 |
| Open | 14.04 |
| Previous Close | 14.01 |
| Day's Range | 13.59 - 14.38 |
| 52-Week Range | 6.45 - 19.45 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 18.78 (+33.57%) |
| Earnings Date | Nov 10, 2026 |
About LMRI
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Financial Performance
In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $18.78, which is an increase of 33.57% from the latest price.
News
Lumexa Imaging price target raised to $17 from $13 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on Lumexa Imaging (LMRI) to $17 from $13 and keeps an Overweight rating on the shares. The company needs to sustain…
Lumexa Imaging Opens Three New Imaging Centers in November
New de novo center openings build presence in attractive markets and support long-term growth plans New de novo center openings build presence in attractive markets and support long-term growth plans
Lumexa Imaging announces joint venture with Advocate Health
Lumexa Imaging (LMRI) announced a new joint venture with Advocate Health to expand its outpatient imaging services in Illinois. The agreement builds on the existing partnership and marks Lumexa Imagin...
Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture
10th Health System joint venture expands Lumexa Imaging's geographic footprint and advances its disciplined growth strategy 10th Health System joint venture expands Lumexa Imaging's geographic footpri...
Lumexa Imaging price target raised to $19 from $17 at Raymond James
Raymond James raised the firm’s price target on Lumexa Imaging (LMRI) to $19 from $17 and keeps a Strong Buy rating on the shares. The Q3 results eased concerns around…
Lumexa Imaging Holdings Earnings Call Transcript: Q3 2026
Q3 revenue rose 5% YoY to $272M, adjusted EBITDA increased 11% QoQ to $62.6M, and free cash flow reached $20.6M. FY adjusted EPS guidance rose to $0.86-$0.90, while revenue guidance was reiterated at $1.045B-$1.097B.
Lumexa Imaging Holdings Earnings release: Q3 2026
Lumexa Imaging Holdings released its Q3 2026 earnings on November 10, 2026, summarizing the period's financial results.
Lumexa Imaging Holdings Slides: Q3 2026
Lumexa Imaging Holdings has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 10, 2026.
Lumexa Imaging Holdings Quarterly report: Q3 2026
Lumexa Imaging Holdings has published its Q3 2026 quarterly earnings report on November 10, 2026.
Lumexa Imaging Announces Third Quarter 2026 Results
RALEIGH, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today reported results for the third quarter ended...
Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its third quarter ...
Lumexa Imaging initiated with a Buy at Truist
Truist initiated coverage of Lumexa Imaging (LMRI) with a Buy rating and $18 price target The firm says the diagnostic imaging market is “large, growing and fragmented with plenty of…
Lumexa Imaging initiated with an Overweight at KeyBanc
KeyBanc analyst Matthew Gillmor last night initiated coverage of Lumexa Imaging (LMRI) with an Overweight rating and $18 price target The firm views diagnostic imaging as an attractive subsector in…
Lumexa Imaging initiated with an Overweight at KeyBanc
KeyBanc analyst Matthew Gillmor initiated coverage of Lumexa Imaging (LMRI) with an Overweight rating and $18 price target
Lumexa Imaging Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference
A leading outpatient imaging provider is accelerating growth through de novo expansion, joint ventures with health systems, and a focus on advanced imaging, supported by operational and AI-driven efficiencies. Recent policy trends and resumed M&A activity are expected to further enhance long-term growth and margin expansion.
Lumexa Imaging price target raised to $13 from $9 at Barclays
Barclays raised the firm’s price target on Lumexa Imaging (LMRI) to $13 from $9 and keeps an Overweight rating on the shares. The firm updated models in the healthcare facilities…
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, announced today ...
Lumexa Imaging price target lowered to $16 from $22 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Lumexa Imaging (LMRI) to $16 from $22 and keeps a Buy rating on the shares.
Lumexa Imaging Holdings Earnings Call Transcript: Q2 2026
Q2 saw strong revenue and volume growth, with advanced modalities reaching a record 37.4% of volume and PET volumes up 23.2%. Guidance was reaffirmed, free cash flow hit a record, and new partnerships and technology initiatives are driving expansion.
Lumexa Imaging Holdings Earnings release: Q2 2026
Lumexa Imaging Holdings released its Q2 2026 earnings on August 12, 2026, summarizing the period's financial results.
Lumexa Imaging Holdings Quarterly report: Q2 2026
Lumexa Imaging Holdings has published its Q2 2026 quarterly earnings report on August 12, 2026.
Lumexa Imaging Holdings Slides: Q2 2026
Lumexa Imaging Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 12, 2026.
Lumexa Imaging Announces Second Quarter 2026 Results
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today reported results for the second quarter ende...
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter...
Lumexa Imaging forms strategic joint venture with Hospital for Special Surgery
Lumexa Imaging (LMRI) announced the formation of a strategic joint venture with Hospital for Special Surgery. The collaboration represents Lumexa Imaging’s ninth joint venture. Lumexa Imaging and HSS ...